DERM
HEALTHCAREJourney Medical Corp
$5.21+0.03 (+0.58%)LIVE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving DERM Today?
No stock-specific AI insight has been generated for DERM yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$4.31$9.55
$5.21
Fundamentals
Market Cap$142M
P/E Ratio—
EPS$-0.47
Dividend Yield—
Dividend / Share—
ROE-0.4%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume230K
Avg Volume (10D)—
Shares Outstanding21.3M
DERM News
21 articles- Aurinia Pharmaceuticals (AUPH) Q1 Earnings and Revenues Top EstimatesYahoo Finance·May 7, 2026
- Zevra Therapeutics (ZVRA) Q1 Earnings and Revenues Surpass EstimatesYahoo Finance·May 6, 2026
- Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026Yahoo Finance·May 6, 2026
- Will Journey Medical Corporation (DERM) Report Negative Q1 Earnings? What You Should KnowYahoo Finance·May 6, 2026
- Assertio (ASRT) Moves 17.0% Higher: Will This Strength Last?Yahoo Finance·May 5, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERMGlobeNewswire Inc.·Apr 28, 2026
- Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™Yahoo Finance·Apr 21, 2026
- Why The Journey Medical (DERM) Narrative Is Shifting With New Targets And Going Concern RisksYahoo Finance·Mar 30, 2026
- Journey Medical (DERM) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesYahoo Finance·Mar 26, 2026
- Journey Medical Corporation Q4 2025 Earnings Call SummaryMoby·Mar 26, 2026
- Journey Medical Corp (DERM) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...Yahoo Finance·Mar 26, 2026
- Journey Medical Q4 Earnings Call HighlightsMarketbeat·Mar 26, 2026
- Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate HighlightsYahoo Finance·Mar 25, 2026
- Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026Yahoo Finance·Mar 18, 2026
- Journey Medical (DERM) Publishes Positive Emrosi Phase 1 Microbiome DataYahoo Finance·Jan 8, 2026
- Public companies account for 34% of Journey Medical Corporation's (NASDAQ:DERM) ownership, while institutions account for 33%Yahoo Finance·Dec 22, 2025
- Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in DermatologyYahoo Finance·Dec 10, 2025
- What Makes Journey Medical Corporation (DERM) a Good Investment?Yahoo Finance·Nov 19, 2025
- Journey Medical Corp (DERM) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ...Yahoo Finance·Nov 18, 2025
- Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key MetricsYahoo Finance·Nov 12, 2025
- Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue EstimatesYahoo Finance·Nov 12, 2025
All 21 articles loaded
Price Data
Open$5.24
Previous Close$5.18
Day High$5.37
Day Low$5.04
52 Week High$9.55
52 Week Low$4.31
52-Week Range
$4.31$9.55
$5.21
Fundamentals
Market Cap$142M
P/E Ratio—
EPS$-0.47
Dividend Yield—
Dividend / Share—
ROE-0.4%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume230K
Avg Volume (10D)—
Shares Outstanding21.3M
About Journey Medical Corp
Dermira, Inc., a biopharmaceutical company, develops and markets therapies for patients with dermatological diseases in the United States.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—